Applications of Pathology-Assisted Image Analysis of Immunohistochemistry-Based Biomarkers in Oncology

Veterinary Pathology

Volumn 51, Issue 1, 2014, Pages 292-303

  Shinde, V ^a   Burke, K E ^a   Chakravarty, A ^a   Fleming, M ^b   McDonald, A A ^c   Berger, A ^a   Ecsedy, J ^a   Blakemore, S J ^a   Tirrell, S M ^a   Bowman, D ^a  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c EPIZYME INC   (United States)

Author keywords

bone marrow aspirate; image analysis; immunohistochemistry; MLN4924; MLN8237; pharmacodynamics

Indexed keywords

((1S,2S,4R)-4-(4-((1S)-2,3-DIHYDRO-1H-INDEN-1-YLAMINO)-7H-PYRROLO(2,3-D)PYRIMIDIN-7-YL)-2-HYDROXYCYCLOPENTYL)METHYL SULPHAMATE; ALISERTIB; AURORA A KINASE; AZEPINE DERIVATIVE; CYCLOPENTANE DERIVATIVE; PHARMACOLOGICAL BIOMARKER; PYRIMIDINE DERIVATIVE;

ALGORITHM; ANIMAL; APOPTOSIS; AUTOMATION; BIOPSY; DRUG DEVELOPMENT; DRUG SCREENING; HUMAN; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; METABOLISM; MITOSIS; NEOPLASM; PATHOLOGY; PROCEDURES; SKIN;

ALGORITHMS; ANIMALS; APOPTOSIS; AURORA KINASE A; AUTOMATION; AZEPINES; BIOMARKERS, PHARMACOLOGICAL; BIOPSY; CYCLOPENTANES; DRUG DISCOVERY; DRUG EVALUATION, PRECLINICAL; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MITOSIS; NEOPLASMS; PYRIMIDINES; SKIN;

EID: 84891717514     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1177/0300985813511124     Document Type: Article

References (17)

1. Beck AH,Sangoi AR,Leung S, et al.Systematic analysis of breast cancer morphology uncovers stromal features associated with survival.Sci Transl Med. 2011;3 (108): 108ra113.
2. Camparo P,Egevad L,Algaba F, et al.Utility of whole slide imaging and virtual microscopy in prostate pathology.APMIS. 2012;120 (4): 298-304.
3. Cervantes A,Elez E,Roda D, et al.Phase I pharmacokinetic/pharmacodynamic study of MLN8237, an investigational, oral, selective Aurora A kinase inhibitor, in patients with advanced solid tumors.Clin Cancer Res. 2012;18 (17): 4764-4774.
4. Dees EC,Cohen RB,von Mehren M, et al.Phase I study of Aurora A kinase inhibitor MLN8237 in advanced solid tumors: safety, pharmacokinetics, pharmacodynamics, and bioavailability of two oral formulations.Clin Cancer Res. 2012;18 (17): 4775-4784.
5. Developer XD 2.0.4: Reference Book. Munich, Germany: Definiens AG;.
6. Ghaznavi F,Evans A,Madabhushi A, et al.Digital imaging in pathology: whole-slide imaging and beyond.Annu Rev Pathol. 2013;8:331-359.
7. Hoar K,Chakravarty A,Rabino C, et al.MLN8054, a small-molecule inhibitor of Aurora A, causes spindle pole and chromosome congression defects leading to aneuploidy.Mol Cell Biol. 2007;27 (12): 4513-4525.
8. Huck JJ,Zhang M,McDonald A, et al.MLN8054, an inhibitor of Aurora A kinase, induces senescence in human tumor cells both in vitro and in vivo.Mol Cancer Res. 2010;8 (3): 373-384.
9. Lloyd MC,Allam-Nandyala P,Purohit CN, et al.Using image analysis as a tool for assessment of prognostic and predictive biomarkers for breast cancer: how reliable is it?.J Pathol Inform. 2010;1:29.
10. Macarulla T,Cervantes A,Elez E, et al.Phase I study of the selective Aurora A kinase inhibitor MLN8054 in patients with advanced solid tumors: safety, pharmacokinetics, and pharmacodynamics.Mol Cancer Ther. 2010;9 (10): 2844-2852.
11. Manfredi MG,Ecsedy JA,Chakravarty A, et al.Characterization of Alisertib (MLN8237), an investigational small-molecule inhibitor of Aurora A kinase using novel in vivo pharmacodynamic assays.Clin Cancer Res. 2011;17 (24): 7614-7624.
12. McDonald A,Burke K,Gao F, et alPharmacodynamic Assays Demonstrate NAE Pathway Inhibition Following Administration of MLN4924 in Patients With Acute Myeloid Leukemia. The Hague, Netherlands: European Hematology Association; 2012:.
13. Muroi K,Nakamurat M,Amemiya Y, et al.Expression of c-kit receptor (CD 117) and CD34 in leukemic cells.Leuk Lymph. 1995;16 ((3-4)): 297-305.
14. Shinde V,Bowman D,Chakravarty A, et alImage Analysis of Chromosome Alignment and Spindle Bipolarity in Mitotic Cells Derived From Tumor Biopsies Treated With an Inhibitor of Aurora A Kinase, MLN8237. Bethesda, MD: American Society for Cell Biology; 2008:.
15. Soucy TA,Dick LR,Smith PG, et al.The NEDD8 conjugation pathway and its relevance in cancer biology and therapy.Genes Cancer. 2010;1 (7): 708-716.
16. Soucy TA,Smith PG,Milhollen MA, et al.An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer.Nature. 2009;458 (7239): 732-736.
17. Swords RT,Kelly KR,Smith PG, et al.Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemia.Blood. 2010;115 (18): 3796-3800.